Pharmaceutical Wastewater Treatment

Pharmaceutical manufacturers must address active pharmaceutical ingredients (APIs) in their wastewater streams. Municipal wastewater treatment plants (WWTPs) and regulatory agencies have begun regulating certain contaminants of concern, and this trend will continue and become more stringent. Contaminants of concern include antibiotics, steroids, hormones and endocrine disrupting compounds (EDCs), and other APIs that have adverse environmental impacts on aquatic life as well as endangering human health when discharged to surface waters. Wastewater treatment must address these residuals as well as the traditional wastewater constituents of BOD, TSS, ammonia, toxicity, and pH.

Xylem has developed a suite of advanced wastewater treatment systems that can tackle the most recalcitrant APIs and endocrine disruptors, as well as traditional contaminants. Wedeco UV and MiPRO advanced oxidation processes destroy bacteria as well as break down recalcitrant APIs. The Leopold Biologically Active Filtration (BAF) completes the offering, which following ozonation, can effectively remove the oxidized API residuals.

In addition, Xylem can bench test and pilot test these processes on a pharmaceutical manufacturer’s wastewater to fine tune the treatment design and demonstrate both the efficacy and efficiency of the selected combination of treatment processes. Manufacturers can insure that the process will work before they invest.

The public trusts the pharmaceutical industry not only to deliver safe compounds to enhance their health, but also to safeguard the environment and public health downstream of their facilities. With Xylem treatment processes, safe, sustainable water practices can be achieved throughout the manufacture and through final discharge.

Products Brands
Brands
Leopold
Leopold

Filtration and clarification solutions for the water and wastewater industry.

Wedeco
Wedeco

Reliable and environmentally-friendly water and wastewater treatment technologies.